ERSOT
BMRN icon

Employees Retirement System of Texas’s BioMarin Pharmaceuticals BMRN Stock Holding History

Employees Retirement System of Texas’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,056
Closed -$58K – 517
2025
Q2 		$58K Buy
+1,056
New +$62.2K ﹤0.01% 473
2024
Q4 		– Sell
-491,100
Closed -$34.5M – 316
2024
Q3 		$34.5M Hold
491,100
– – 0.3% 95
2024
Q2 		$40.4M Buy
491,100
+147,100
+43% +$12.2M 0.38% 85
2024
Q1 		$30M Hold
344,000
– – 0.33% 93
2023
Q4 		$33.2M Hold
344,000
– – 0.39% 89
2023
Q3 		$30.4M Hold
344,000
– – 0.45% 77
2023
Q2 		$29.8M Buy
344,000
+83,000
+32% +$7.81M 0.41% 87
2023
Q1 		$25.4M Hold
261,000
– – 0.37% 83
2022
Q4 		$27M Buy
+261,000
New +$24.5M 0.39% 80
2022
Q3 		– Sell
-22,137
Closed -$1.83M – 396
2022
Q2 		$1.83M Hold
22,137
– – 0.03% 512
2022
Q1 		$1.71M Hold
22,137
– – 0.02% 591
2021
Q4 		$1.96M Hold
22,137
– – 0.02% 559
2021
Q3 		$1.71M Hold
22,137
– – 0.02% 591
2021
Q2 		$1.85M Hold
22,137
– – 0.02% 587
2021
Q1 		$1.67M Hold
22,137
– – 0.02% 618
2020
Q4 		$1.94M Hold
22,137
– – 0.03% 493
2020
Q3 		$1.68M Hold
22,137
– – 0.02% 529
2020
Q2 		$2.73M Hold
22,137
– – 0.04% 402
2020
Q1 		$1.87M Hold
22,137
– – 0.04% 425
2019
Q4 		$1.87M Hold
22,137
– – 0.03% 531
2019
Q3 		$1.49M Buy
+22,137
New +$1.71M 0.02% 598
2019
Q2 		– Sell
-88,110
Closed -$7.83M – 1092
2019
Q1 		$7.83M Sell
88,110
-19,819
-18% -$1.84M 0.12% 203
2018
Q4 		$9.19M Buy
107,929
+11,411
+12% +$1.09M 0.15% 155
2018
Q3 		$9.36M Sell
96,518
-61,781
-39% -$6.17M 0.12% 188
2018
Q2 		$14.9M Hold
158,299
– – 0.2% 106
2018
Q1 		$12.8M Buy
158,299
+53,644
+51% +$4.6M 0.17% 128
2017
Q4 		$9.33M Buy
+104,655
New +$9.1M 0.12% 214

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Employees Retirement System of Texas's BMRN Position: Q3 2025 in Review

Employees Retirement System of Texas sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2025, closing a stake of 1,056 shares — an estimated $58K sold.

Employees Retirement System of Texas first reported a position in BMRN in Q4 2017 and held it in 27 quarters. The position peaked at $40.4M in Q2 2024. 577 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

  • Employees Retirement System of Texas reported no remaining BioMarin Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 1,056 BioMarin Pharmaceuticals shares in Q3 2025, an estimated $58K.
  • Employees Retirement System of Texas first reported a position in BioMarin Pharmaceuticals in Q4 2017 and held it in 27 quarters.
  • Employees Retirement System of Texas's BioMarin Pharmaceuticals position peaked at $40.4M in Q2 2024.
  • 577 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on Employees Retirement System of Texas's 13F filing for Q3 2025, filed 13 Nov 2025.